Key Kidney Antibodies

Kidney Antibodies

Kidney cancers are the ninth most diagnosed cancer in the United States, with about 3.7% of new cancer cases classified as renal and contributing toward 2.4% of cancer deaths yearly. As of 2012, there were approximately 376,000 people living with kidney cancer in the United States. Those diagnosed with kidney cancer have a 5 year survival rate of 73.2%. Over the last 10 years, the rate of new kidney cancer cases has risen 1.4% per year, while the death rate has fallen 0.7% per year. Biocare Medical is proud to offer key kidney antibodies that may aid in the identification of their respective proteins by IHC in FFPE tissues.

SEER Cancer Statistics Factsheets: Kidney and Renal Pelvis Cancer. National Cancer Institute. Bethesda, MD,

Biocare Clone

PAX8 (M)